The Sympathetic Nervous System in Hypertensive Heart Failure with Preserved LVEF
Journal of Clinical Medicine · 12.10.2023 · 12 (20) · 6486
DOI: 10.3390/jcm12206486 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 12.10.2023. Verfasst von Filippos Triposkiadis und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, European University Cyprus, Nicosia 2404, Cyprus. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Herzinsuffizienz
Abstract (Originalsprache)
The neurohormonal model of heart failure (HF) pathogenesis states that a reduction in cardiac output caused by cardiac injury results in sympathetic nervous system (SNS) activation, that is adaptive in the short-term and maladaptive in the long-term. This model has proved extremely valid and has been applied in HF with a reduced left ventricular (LV) ejection fraction (LVEF). In contrast, it has been undermined in HF with preserved LVEF (HFpEF), which is due to hypertension (HTN) in the vast majority of the cases. Erroneously, HTN, which is the leading cause of cardiovascular disease and premature death worldwide and is present in more than 90% of HF patients, is tightly linked with SNS overactivity. In this paper we provide a contemporary overview of the contribution of SNS overactivity to the development and progression of hypertensive HF (HHF) as well as the clinical implications resulting from therapeutic interventions modifying SNS activity. Throughout the manuscript the terms HHF with preserved LVEF and HfpEF will be used interchangeably, considering that the findings in most HFpEF studies are driven by HTN.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Medicine, European University Cyprus, Nicosia 2404, Cyprus.
- Department of Therapeutics, Heart Failure and Cardio-Oncology Clinic, National and Kapodistrian University of Athens, 115 27 Athens, Greece.
- Department of Nephrology, Hippokration Hospital, Aristotle University of Thessaloniki, 541 24 Thessaloniki, Greece.
- Unit of Quality Improvement, Department of Cardiothoracic Surgery, University of Thessaly, 411 10 Biopolis, Greece.
- Department of Surgery and Cancer, Imperial College London, St Mary's Hospital, London W2 1NY, UK.
- 6th Department of Cardiology, Hygeia Hospital, 151 23 Athens, Greece.
ORCID-Profile: Filippos Triposkiadis, Alexandros Briasoulis, Pantelis Sarafidis, Ioannis Paraskevaidis, John Skoularigis, Andrew Xanthopoulos
Zitieren
APA
Triposkiadis, F., Briasoulis, A., Sarafidis, P., Magouliotis, D., Athanasiou, T., Paraskevaidis, I., Skoularigis, J., & Xanthopoulos, A. (2023). The Sympathetic Nervous System in Hypertensive Heart Failure with Preserved LVEF. Journal of Clinical Medicine, 12(20), 6486. https://doi.org/10.3390/jcm12206486
Vancouver
Triposkiadis F, Briasoulis A, Sarafidis P, Magouliotis D, Athanasiou T, Paraskevaidis I, et al. The Sympathetic Nervous System in Hypertensive Heart Failure with Preserved LVEF. Journal of Clinical Medicine. 2023;12(20):6486. doi:10.3390/jcm12206486
BibTeX
@article{Triposkiadis2023,
author = {Triposkiadis, Filippos and Briasoulis, Alexandros and Sarafidis, Pantelis and Magouliotis, Dimitrios and Athanasiou, Thanos and Paraskevaidis, Ioannis and Skoularigis, John and Xanthopoulos, Andrew},
title = {The Sympathetic Nervous System in Hypertensive Heart Failure with Preserved LVEF},
journal = {Journal of Clinical Medicine},
year = {2023},
volume = {12},
number = {20},
pages = {6486},
doi = {10.3390/jcm12206486}
}
EUVIMED